Akebia Therapeutics, Inc.AKBANASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank92
Studio
Year-over-Year Change

Return on invested capital

Latest
9.26%
↑ 122% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive growthExpanding
Average
-41.33%
Historical baseline
PeriodValueYoY Change
20259.26%+127.4%
2024-33.77%-21.1%
2023-27.89%+9.1%
2022-30.68%+57.0%
2021-71.36%+12.7%
2020-81.73%-66.0%
2019-49.23%-146.8%
2018-19.95%+43.0%
2017-35.02%+52.0%
2016-72.90%-